Partner Article

Smith & Nephew push for emerging market growth

Hull-founded medical technology business, Smith & Nephew has reported a 1% increase in revenues, year-on-year.

The London-headquartered global business will acquire an Indian trauma business and their Brazilian distributor as part of a push to capitalize on growth in emerging and international markets.

Trading profit at the firm was $241m in March 2013, compared with $252m in March 2012.

Olivier Bohuon, CEO of Smith & Nephew, said: “Smith & Nephew has consistently delivered revenue and earnings growth together with strong cash generation in the challenging markets of the last few years.

“We will continue to invest in our growth products, franchises and geographies and maintain adequate headroom for further significant acquisitions. We have increased the level of dividend and moved to a progressive policy. Further to these commitments, today we are announcing the start of a share buy-back programme to return $300 million of surplus capital to our shareholders.”

This was posted in Bdaily's Members' News section by Tom Keighley .